Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • Article
  • Research Policy

The Career Effects of Scandal: Evidence from Scientific Retractions

By: Pierre Azoulay, Alessandro Bonatti and Joshua Lev Krieger
  • Format:Print
ShareBar

Abstract

We investigate how the scientific community's perception of a scientist's prior work changes when one of his articles is retracted. Relative to non-retracted control authors, faculty members who experience a retraction see the citation rate to their earlier, non-retracted articles drop by 10% on average, consistent with the Bayesian intuition that the market inferred their work was mediocre all along. We then investigate whether the eminence of the retracted author and the cause of the retraction (fraud vs. mistake) shape the magnitude of the penalty. We find that eminent scientists are more harshly penalized than their less distinguished peers in the wake of a retraction, but only in cases involving fraud or misconduct. When the retraction event had its source in “honest mistakes,” we find no evidence of differential stigma between high- and low-status faculty members.

Keywords

Reputation; Perception; Status and Position; Outcome or Result

Citation

Azoulay, Pierre, Alessandro Bonatti, and Joshua Lev Krieger. "The Career Effects of Scandal: Evidence from Scientific Retractions." Research Policy 46, no. 9 (November 2017).
  • Find it at Harvard

About The Author

Joshua Lev Krieger

Entrepreneurial Management
→More Publications

More from the Authors

    • March 2022
    • Faculty Research

    Tomorrow.io Goes To Space

    By: Joshua Lev Krieger, Abhishek Nagaraj and James Barnett
    • March 2022
    • Faculty Research

    Biobot Analytics

    By: Ray Kluender, Joshua Krieger and Mitch Weiss
    • 2022
    • Review of Financial Studies

    Missing Novelty in Drug Development

    By: Joshua Krieger, Danielle Li and Dimitris Papanikolaou
More from the Authors
  • Tomorrow.io Goes To Space By: Joshua Lev Krieger, Abhishek Nagaraj and James Barnett
  • Biobot Analytics By: Ray Kluender, Joshua Krieger and Mitch Weiss
  • Missing Novelty in Drug Development By: Joshua Krieger, Danielle Li and Dimitris Papanikolaou
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College